Investigational drug · Phase 3
IHAT
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Iron-deficiency.
Phase 3Last checked: Nov 19, 2026Latest source record: Jun 4, 2025 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
2
0 still active
All registered trials
2
Any phase or sponsor naming "IHAT"
First trial start
2024
Mar 5, 2024
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "IHAT", any sponsor or status.
Conditions studied
As listed on its trial records.
- Iron-deficiency
Approved drugs for the same conditions: Rare and genetic disease
Largest trials
Live from ClinicalTrials.gov: studies naming "IHAT" as an intervention, largest first.
- Safety and Effectiveness of IHAT in Iron Deficient Pre-menopausal WomanPivotal-lookingCompleted
RDC Clinical Pty LtdIndustry
NCT05950841 · 180 participants · Start Mar 6, 2024 · Primary completion Feb 3, 2025
Drug: Low dose IHAT; High Dose IHAT and 1 more · For: Iron-deficiency
Sites: New Farm, Australia
- Safety and Effectiveness of Iron Hydroxide Adipate Tartrate (IHAT) in Iron Deficient Premenopausal WomenPivotal-lookingCompleted
Nemysis LtdIndustry
NCT06285799 · 180 participants · Start Mar 5, 2024 · Primary completion Feb 11, 2025
Drug: Low Dose IHAT; High Dose IHAT and 1 more · For: Iron-deficiency
Sites: Brisbane, Australia
Newest research
PubMed records naming it or its code names, newest first.
- Serotyping and Seroprevalence Estimation of Pasteurellosis in Ovine and Caprine in Selected Districts of Afar Region, Ethiopia.
Dubie T, Abera B, Hamid M, et al. · Vet Med Sci 2026
- Prevotella stercorea links gut microbiome ecology to respiratory infection protection through host-context-dependent, richness-independent associations.
Ofordile O · BMC Med Genomics 2026
- Real-World Effectiveness of IHATTM in Women with Iron Deficiency Across Pregnancy, Postpartum and Abnormal Uterine Bleeding.
Saccone G, Motta M, De Seta F, et al. · Nutrients 2026
- Seroprevalence and molecular detection of toxoplasma gondii in sheep and pigs in Xinjiang Uygur autonomous region, China.
Liu WG, Huang J, Maihemuti M, et al. · Food Waterborne Parasitol 2026
- Gut Prevotella stercorea associates with protection against infection in rural African children.
Ofordile O, Pereira DIA, Prentice AM, et al. · Nat Commun 2025
- Seroprevalence and molecular detection of Toxoplasma gondii and Neospora caninum in beef cattle and goats in Hunan province, China.
Yi XL, Yang WH, Zheng HL, et al. · Parasit Vectors 2024
Also in development for Iron-deficiency
- Carob FlourPhase 32 trials
Nemysis Ltd · Iron-deficiency
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.